← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Tirofibanhydrochlorid-Monohydrat currently has availability issues reported in 3 European registers: Austria, Germany, Greece.
Shortage ATC B01AC17 · also listed as: TIROFIBAN HYDROCHLORID · Tirofibanhydrochlorid-Monohydrat · data refreshed 11 September 2026
As of 11 September 2026, 3 of the 9 tracked registers list current availability issues for Tirofibanhydrochlorid-Monohydrat, covering 3 affected product presentations. The longest-running open report was filed in Austria on 2026-04-28 and has now been open for about 5 months. Where agencies state a cause, manufacturing problems lead with 1 of the 2 stated-cause reports, followed by delivery delays with 1. The furthest expected-resolution date currently on file is 2026-10-15; the earliest is 2026-09-15. Registers in Germany, Greece indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Tirofibanhydrochlorid-Monohydrat is coded B01AC17 — a medicine acting on blood and blood-forming organs — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Aggrastat 50 Mikrogramm/ml - Infusionslösung | 2026-04-28 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Aggrastat 50 Mikrogramm/ml Infusionslösung | 2026-07-01 | 2026-10-15 | Probleme in der Herstellung Alternatives: Aggrastat 250 Mikrogramm/ml Konzentrat zur Herstellung einer Infusionslösung - Einreichungsnummer: 2142618 | register ↗ |
| 🇬🇷 Greece | Limited availability AGGRAFIBAN C/S.SOL.IN 0.25MG/ML 1 BOTTLE x 50 ML | 2026-05-20 | 2026-09-15 | WIN MEDICA A.E., ΕΛΛΑΔΑ Καθυστέρηση παράδοσης Εναλλακτικά άλλο σκεύασμ Alternatives: Ποιοτικό πρόβλημα - Δραστική Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και | register ↗ |
Every individual register entry for Tirofibanhydrochlorid-Monohydrat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Aggrastat 50 Mikrogramm/ml Infusionslösung | Shortage | 2026-07-01 | 2026-10-15 | Probleme in der Herstellung |
| 🇬🇷 GR | AGGRAFIBAN C/S.SOL.IN 0.25MG/ML 1 BOTTLE x 50 ML | Limited availability | 2026-05-20 | 2026-09-15 | WIN MEDICA A.E., ΕΛΛΑΔΑ Καθυστέρηση παράδοσης Εναλλακτικά άλ |
| 🇦🇹 AT | Aggrastat 50 Mikrogramm/ml - Infusionslösung | Shortage | 2026-04-28 | — |
Yes. As of 11 September 2026, availability issues are reported in: Austria, Germany, Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-15 to 2026-10-15. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Tirofibanhydrochlorid-Monohydrat: BASG (Austria), BfArM (Germany), EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Tirofibanhydrochlorid-Monohydrat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/tirofibanhydrochlorid-monohydrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Tirofibanhydrochlorid-Monohydrat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/tirofibanhydrochlorid-monohydrat/">Tirofibanhydrochlorid-Monohydrat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>